Search

everythinglearnresearchcommunity

for

Search:↓

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Pegvaliase is recommended for treating adults with phenylketonuria.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

The exosome injections were from stem cells and plants, not umbilical cords.

Managing multiple autoimmune diseases in one patient is very challenging.

Identifying and managing risk factors before cataract surgery is crucial to prevent complications.

A malpractice lawsuit was filed over improper delegation in a hair transplant procedure.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

The Seoul International Dermatology Symposium was a successful event that highlighted new dermatology treatments and fostered international relations.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

Selective chemical epilation effectively treats tinea capitis without harmful side effects.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Ruxolitinib helped a patient with alopecia areata regrow hair.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

The conclusion of the case is not provided in the summary.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Epidermal growth factor helps hair regrow after chemotherapy.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Certain medications and smaller pupil size increase the risk of intraoperative floppy iris syndrome during eye surgery.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.